Monday 30 April 2018

Monash Haematology Journal Club: ‘ The management of relapsed/refractory Hodgkin’s Lymphoma’, 2 May

7.30am, 2 May, Lecture Theatre 2, MMC

Dr Martin Hutchings
Department of Haematology
The Finsen Centre, National Hospital, Copenhagen University Hospital Copenhagen, Denmark

Walter and Eliza Hall Institute of Medical Research

Dr. Martin Hutchings received his medical degree and his PhD at the University of Copenhagen, Denmark. He is a staff specialist, Department of Hematology, at the Finsen Centre, National Hospital, Copenhagen University Hospital in Denmark. Dr. Hutchings is chairman of the Scientific Steering Committee for the EORTC Lymphoma Group and principal investigator for the EORTC H11 randomized trial. His Main research areas Hodgkin lymphoma; Mantle cell lymphoma; PET/CT in lymphoma; PET-response adapted lymphoma treatment; Phase 1 haematology studies. 

In addition, he is a peer-reviewer for numerous journals including Haematologica, Clinical Cancer Research, Annals of Oncology, Journal of Clinical Oncology, Journal of Nuclear Medicine, Journal of Pediatric Hematology and Oncology, Bone Marrow Transplant, American Journal of Hematology, Radiation Oncology, Leukemia and Lymphoma, Lancet Oncology, and International Journal of Radiation Oncology. Dr. Hutchings has given many lectures and written numerous peer-reviewed articles on the treatment of Hodgkin lymphoma.

No comments:

Post a Comment